{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:30:14Z","timestamp":1790793014799,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017957","name":"Health Commission of Guizhou Province","doi-asserted-by":"publisher","award":["gzwkj2024-101"],"award-info":[{"award-number":["gzwkj2024-101"]}],"id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["gyfyxkrc-2023-02"],"award-info":[{"award-number":["gyfyxkrc-2023-02"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["[2021] 094"],"award-info":[{"award-number":["[2021] 094"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["MS[2025]448"],"award-info":[{"award-number":["MS[2025]448"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260129"],"award-info":[{"award-number":["82260129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060116"],"award-info":[{"award-number":["82060116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cellsig.2026.112369","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:36:41Z","timestamp":1768635401000},"page":"112369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["AKR1C3 promotes aerobic glycolysis in hepatic stellate cells via the AKT\/mTOR pathway to induce liver fibrosis"],"prefix":"10.1016","volume":"141","author":[{"given":"Tao","family":"Ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-xiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-yuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-mei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-qian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2026.112369_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112369_bb0010","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.cell.2019.07.021","article-title":"LECT2, a ligand for Tie1, plays a crucial role in liver Fibrogenesis","volume":"178","author":"Xu","year":"2019","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112369_bb0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112369_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112369_bb0025","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112369_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.31083\/j.fbl2909321","article-title":"A new target for hepatic fibrosis prevention and treatment: the Warburg effect","volume":"29","author":"Pan","year":"2024","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112369_bb0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.hbpd.2021.04.010","article-title":"Mitochondria: a critical hub for hepatic stellate cells activation during chronic liver diseases","volume":"20","author":"Ezhilarasan","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112369_bb0040","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.201508-1699ED","article-title":"Aerobic glycolysis and the Warburg effect. An unexplored realm in the search for fibrosis therapies?","volume":"192","author":"Maher","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cellsig.2026.112369_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fcell.2018.00150","article-title":"Role of metabolism in hepatic stellate cell activation and fibrogenesis","volume":"6","author":"Hou","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112369_bb0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3748\/wjg.v28.i1.123","article-title":"Focal adhesion kinase-related non-kinase ameliorates liver fibrosis by inhibiting aerobic glycolysis via the FAK\/Ras\/c-myc\/ENO1 pathway","volume":"28","author":"Huang","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellsig.2026.112369_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156047","article-title":"Catalpol ameliorates liver fibrosis via inhibiting aerobic glycolysis by EphA2\/FAK\/Src signaling pathway","volume":"135","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"issue":"40","key":"10.1016\/j.cellsig.2026.112369_bb0060","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.3748\/wjg.v27.i40.6908","article-title":"Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells","volume":"27","author":"Zhou","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellsig.2026.112369_bb0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cbi.2015.09.006","article-title":"In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis","volume":"240","author":"Zhao","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112369_bb0070","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/ijc.31954","article-title":"Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis","volume":"144","author":"Huebbers","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.cellsig.2026.112369_bb0075","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/acs.jmedchem.9b02138","article-title":"Overview of AKR1C3: inhibitor achievements and disease insights","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112369_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cbi.2014.09.024","article-title":"The aldo-keto reductases (AKRs): overview","volume":"234","author":"Penning","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112369_bb0085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.urolonc.2018.07.005","article-title":"AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling","volume":"36","author":"Wang","year":"2018","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112369_bb0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mce.2015.07.008","article-title":"11\u03b2-prostaglandin F2\u03b1, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer","volume":"413","author":"Yoda","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112369_bb0095","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-20-2480","article-title":"A positive feedback loop of AKR1C3-mediated activation of NF-\u03baB and STAT3 facilitates proliferation and metastasis in hepatocellular carcinoma","volume":"81","author":"Zhou","year":"2021","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112369_bb0100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mc.23527","article-title":"AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP\/SLC7A11 signaling pathway","volume":"62","author":"Chen","year":"2023","journal-title":"Mol. Carcinog."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112369_bb0105","first-page":"4515","article-title":"AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: database mining in malignancies","volume":"18","author":"Zhao","year":"2019","journal-title":"Oncol. Lett."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112369_bb0110","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.7150\/thno.74974","article-title":"AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy","volume":"12","author":"Wu","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112369_bb0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13293-023-00553-4","article-title":"Two genetic variants in the SRD5A2 gene are found to be associated with sex differences in the disease characteristics of patients with chronic hepatitis B virus infection","volume":"14","author":"Duan","year":"2023","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.cellsig.2026.112369_bb0120","article-title":"Integrated bioinformatical and in vitro study on drug targets for liver cirrhosis based on unsupervised consensus clustering and immune cell infiltration","volume":"13","author":"Chi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112369_bb0125","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2147\/DDDT.S194787","article-title":"Salvianolic acid A attenuates CCl(4)-induced liver fibrosis by regulating the PI3K\/AKT\/mTOR, Bcl-2\/Bax and caspase-3\/cleaved caspase-3 signaling pathways","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112369_bb0130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s10637-014-0130-5","article-title":"In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17\u03b2-hydroxysteroid dehydrogenase type 5 (17\u03b2HSD5; AKR1C3)","volume":"32","author":"Kikuchi","year":"2014","journal-title":"Invest. New Drugs"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112369_bb0135","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1111\/liv.16094","article-title":"Fibrosis, biomarkers and liver biopsy in AAT deficiency and relation to liver Z protein polymer accumulation","volume":"44","author":"Suri","year":"2024","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112369_bb0140","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41401-021-00674-9","article-title":"S-nitrosylation of c-Jun N-terminal kinase mediates pressure overload-induced cardiac dysfunction and fibrosis","volume":"43","author":"Zhou","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cellsig.2026.112369_bb0145","article-title":"Berberine ameliorates inflammation in acute lung injury via NF-\u03baB\/Nlrp3 signaling pathway","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Nutr."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112369_bb0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41401-021-00658-9","article-title":"Bmal1 inhibits phenotypic transformation of hepatic stellate cells in liver fibrosis via IDH1\/\u03b1-KG-mediated glycolysis","volume":"43","author":"Xu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"31","key":"10.1016\/j.cellsig.2026.112369_bb0155","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1038\/s41388-022-02379-7","article-title":"AKR1C3 regulated by NRF2\/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma","volume":"41","author":"Pan","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2026.112369_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s11658-019-0179-4","article-title":"Costunolide reduces glycolysis-associated activation of hepatic stellate cells via inhibition of hexokinase-2","volume":"24","author":"Ban","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112369_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111339","article-title":"Mechanisms underlying cell therapy in liver fibrosis: an overview","volume":"8","author":"Pinheiro","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cellsig.2026.112369_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Aspects Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112369_bb0175","first-page":"1","article-title":"Regression of liver fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin. Liver Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112369_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuad049","article-title":"Methodologies for bacterial ribonuclease characterization using RNA-seq","volume":"47","author":"Broglia","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112369_bb0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00018-024-05114-5","article-title":"KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3\/Akt\/mTOR pathway","volume":"81","author":"Zhang","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112369_bb0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41419-021-03596-w","article-title":"The fatty acid receptor CD36 promotes HCC progression through activating Src\/PI3K\/AKT axis-dependent aerobic glycolysis","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"issue":"7\u20138","key":"10.1016\/j.cellsig.2026.112369_bb0195","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s10495-023-01838-0","article-title":"SLITRK6 promotes the progression of lung adenocarcinoma by regulating PI3K\/AKT\/mTOR signaling and Warburg effect","volume":"28","author":"Yu","year":"2023","journal-title":"Apoptosis"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112369_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091459","article-title":"Overexpression of renin-B induces Warburg-like effects that are associated with increased AKT\/mTOR signaling","volume":"11","author":"Golchert","year":"2022","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.cellsig.2026.112369_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212512","article-title":"Transcriptomic profiling reveals AKR1C1 and AKR1C3 mediate cisplatin resistance in signet ring cell gastric carcinoma via autophagic cell death","volume":"22","author":"Phoo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112369_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031471","article-title":"Androgen and estrogen \u03b2 receptor expression enhances efficacy of antihormonal treatments in triple-negative breast cancer cell lines","volume":"25","author":"Crespo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112369_bb0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.chembiol.2024.07.011","article-title":"Human AKR1C3 binds agonists of GPR84 and participates in an expanded polyamine pathway","volume":"32","author":"Dudkina","year":"2025","journal-title":"Cell Chem. Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112369_bb0220","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","article-title":"AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112369_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158142","article-title":"Threonine deficiency increases triglyceride deposition in primary duck hepatocytes by reducing STAT3 phosphorylation","volume":"25","author":"Zhuang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112369_bb0230","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112781119","article-title":"Chronic inflammatory arthritis drives systemic changes in circadian energy metabolism","volume":"119","author":"Downton","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2026.112369_bb0235","article-title":"Knockdown of AKR1C3 promoted sorafenib sensitivity through inhibiting the phosphorylation of AKT in hepatocellular carcinoma","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112369_bb0240","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/s41598-025-31533-w","article-title":"Network pharmacology identifies AKR1C3 and KYNU as potential targets of Astragalus Membranaceus and Ephedra in pediatric obesity-associated asthma","volume":"16","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112369_bb0245","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2478\/s11658-008-0025-6","article-title":"Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissue","volume":"13","author":"Svensson","year":"2008","journal-title":"Cell. Mol. Biol. Lett."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:44:29Z","timestamp":1776825869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"alternative-id":["S0898656826000185"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112369","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AKR1C3 promotes aerobic glycolysis in hepatic stellate cells via the AKT\/mTOR pathway to induce liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112369"}}